Last updated on 24 Apr 2025
Owner Info
Quince Therapeutics, Inc.
601 Gateway Blvd., Suite 1250
South San Francisco CA 94080, UNITED STATES OF AMERICA
Serial Number
2345587 filed on 27 Oct 2022
Correspondent
Jeffrey Greene
Foley & Lardner LLP,,
90 Park Ave, 37th Floor,
UNITED STATES OF AMERICA
2345587
27 Oct 2022
27 Oct 2032
WORD
27 Apr 2022
US
Status Date | Action Taken |
---|---|
24th Apr 2025 | International Registration in Australia Protected After Adverse (Amendments) correspondence sent |
23rd Apr 2025 | International Registration in Australia Protected After Adverse (Amendments) correspondence sent |
23rd Apr 2025 | IP Right Registration Published |
23rd Apr 2025 | Status change to Registered/Protected |
25th Feb 2025 | Refund - Waiver Notice correspondence sent |
18th Feb 2025 | General Request Initiated |
15th Feb 2025 | Application Accepted correspondence sent |
14th Feb 2025 | Application Accepted correspondence sent |
14th Feb 2025 | IP Right has been Examined |
14th Feb 2025 | IP Right Acceptance Published |